PExI
This core metric managed closely by PSP reflects the extent to which patients take their medication as prescribed
What is Adherence?
These key tools used by the HEOR team help develop a compelling Value story for Access.
What are economic models and budget impact analyses?
This authority governs and enforces compliance for our list prices
What is the PMPRB?
This Field Access activity begins before HTA review starts and helps shape early strategic planning for new products.
What is NPP Support?
These main external stakeholders that the Patient Access Leads engages with and what role does each plan in access decisions
Who are HCPs and PAGs?
This Novartis Canada platform serves as the single, standardized entry point that guides teams through evaluating, approving, and implementing innovation projects.
What is Innovation Front Door?
This process does not allow for a Reconsideration when a Recommendation is issued
What is INESSS submission?
The name of the system‑integration project we are currently working on
What is LDC?
This document captures the outcome of national price negotiations, guides subsequent provincial deal execution - the field access team also tracks to time field activation!
What is pCPA LOI?
These are the cross-functional product teams the patient access strategy team interfaces with to optimize the launch of a new product
Who is Everyone? Commerical team, PSP, medical, gov affairs, and patient advocacy/comms, and closely with HEOR, Pricing, and Field Access
The name of the oversight Oversight Committee that gathers cross functional departments to review various aspects of a NVS PSP (from launch/initial approval, changes and ongoing annual for a Periodic Review).
What is PSPOC?
CDA and INESSS typically cite these cost effectiveness willingness to pay thresholds
What are 50k and 100k/QALY?
The four core activities our pricing team performs daily
What is invoice validation, contract management, adherence to pricing regulations, and access analytics?
This documentation required by many plans confirms clinical criteria before coverage - materials that the field access team helps clarify and circulate to internal stakeholders.
What is prior authorization?
This is how Market Access balances speed to access while preserving value (price potential)
What is assessing the competitive landscape, early market shaping, engaging stakeholder early while articulating the value proposition, differentiating the asset meaningfully?
This major private payer does not permit back dating SAs and thus limits retro billing opportunities.
What is Sunlife?
At time of HTA submission we often have clinical trials which meet our regulatory needs (clinical efficacy), how do we overcome the need for comparative clinical information
What are indirect treatment comparisons?
These key financial and strategy factors are assessed by Pricing team when evaluating a proposed contract or tender
What is net price implications, contract profitability, payer behavior, and portfolio interactions?
This performance indicator is a key measure to ensure appropriate inventory levels at wholesalers and avoid peaks and valleys in sales
What is Stock in Trade?
The two activities Patient Access Strategy conducts when negotiations stall.
What is exploring innovative agreements and external advocacy?
The approximate total amount of copay investment in 2025
What is $83.6M CAD?
This early strategic HEOR activity identifies the clinical and economic data that will be missing by the time of HTA submissions, enabling the team to "start early" in closing these gaps with initiatives such as RWE studies.
What is HTA gap analysis?
These governance steps must be ensured before a pricing or contracting decision can be approved
What is alignment with international pricing policy through PricePro, completion of compliance checks, proper documentation, integration with approval workflows, and review of financial modeling assumptions?
To confirm private payer systems have been updated to list a new DIN/strength of a drug the Field access team often partners with PSP to run real-world claims through plan systems.
What is test billing?
The average wait time for Canadian patients to obtain public access to these therapies.
What is an average of 500 days?